Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy

BACKGROUND: Hepcidin, as a regulator of body iron stores, has been recently discovered to play a critical role in the pathogenesis of anemia of chronic disease. Atherosclerotic cardiovascular disease is the most common complication and the leading cause of death in chronic hemodialysis (CHD) patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Han, Feng, Su-Juan, Su, Lu-Lu, Wang, Wei, Zhang, Xiao-Dong, Wang, Shi-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830316/
https://www.ncbi.nlm.nih.gov/pubmed/25963357
http://dx.doi.org/10.4103/0366-6999.156781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830316/
https://www.ncbi.nlm.nih.gov/pubmed/25963357
http://dx.doi.org/10.4103/0366-6999.156781

Ejemplares similares